Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Renapharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 36,750 Less Arrow 30,599 Less Arrow 28,528
Financial expenses 0 More Arrow 78 Less Arrow 30
Earnings before taxes 5,514 More Arrow 6,689 More Arrow 6,975
EBITDA 8,113 Less Arrow 7,264 More Arrow 7,472
Total assets 42,617 More Arrow 44,840 Less Arrow 35,128
Current assets 19,903 More Arrow 21,969 Less Arrow 18,389
Current liabilities 4,290 More Arrow 9,790 Less Arrow 7,291
Equity capital 32,185 Less Arrow 26,842 Less Arrow 18,819
- share capital 103 Less Arrow 101 Less Arrow 95
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 75.5% Less Arrow 59.9% Less Arrow 53.6%
Turnover per employee 9,188 Less Arrow 7,650 Less Arrow 7,132
Profit as a percentage of turnover 15.0% More Arrow 21.9% More Arrow 24.4%
Return on assets (ROA) 12.9% More Arrow 15.1% More Arrow 19.9%
Current ratio 463.9% Less Arrow 224.4% More Arrow 252.2%
Return on equity (ROE) 17.1% More Arrow 24.9% More Arrow 37.1%
Change turnover 5,600 Less Arrow 47 More Arrow 6,674
Change turnover % 18% Less Arrow 0% More Arrow 31%
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 33%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.